Skip to main content
. 2021 Jan 9;2021:8729869. doi: 10.1155/2021/8729869

Table 4.

Univariate and multivariate analyses of GCLM patients with and without hepatectomy.

Variables Patients undergoing hepatectomy Patients without hepatectomy
Univariable Multivariable Univariable Multivariable
HR 95% CI P HR 95% CI P HR 95% CI P HR 95% CI P
Gender 0.684 0.386-1.213 0.194 0.356 0.969-1.896 0.085
Age 0.858 0.537-1.369 0.520 1.462 1.117-1.913 0.006 1.225 0.933-1.609 0.144
T stage 1.012 0.635-1.613 0.961 0.899 0.684-1.182 0.446
N stage 0.586 0.365-0.942 0.027 0.641 0.389-1.057 0.082 1.071 0.816-1.408 0.620
Number of liver metastases 0.847 0.528-1.359 0.491 1.016 0.774-1.335 0.906
Chemotherapy 1.662 1.040-2.657 0.034 1.635 1.007-2.654 0.047 1.323 1.012-1.731 0.041 1.283 0.978-1.682 0.072
Ascites 1.606 0.821-3.144 0.167 1.064 0.777-1.458 0.698
Peritoneal metastasis 0.172 0.641-2.114 0.606 1.255 0.916-1.719 0.157
HR 0.334 0.191-0.584 <0.001 0.288 0.199-0.417 <0.001
PLR 1.423 0.890-2.275 0.140 1.644 1.235-2.188 0.001
PNI 0.539 0.333-0.871 0.012 0.794 0.467-1.352 0.396 0.828 0.635-1.080 0.164
NLR 1.209 0.756-1.933 0.428 1.221 0.933-1.599 0.146
HR+PLR 2.288 1.566-3.344 <0.001 1.933 1.246-2.998 0.003 2.215 1.757-2.793 <0.001 2.143 1.698-2.705 <0.001

HR: hazard ratio; 95% CI: 95% confidence interval.